Clinical Trial Update: Nicotine Skin Patch in Treating Patients With Kaposi's Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial of a nicotine transdermal patch for Kaposi's sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposi Sarcoma

Drugs mentioned

• Nicotine transdermal patch (nicotine patch)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Sarcoma | Phase 2 | Status: COMPLETED